Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysisIrene Tramacere, Graziella Filippini, Cinzia Del Giovane et al.|Cochrane Database of Systematic Reviews|2015Cited by 212
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysisGraziella Filippini, Georgia Salanti, Cinzia Del Giovane et al.|Cochrane Database of Systematic Reviews|2013Cited by 185
Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised PatientsLuca Richeldi, Leonardo M. Fabbri, Roberto Esposito et al.|CHEST Journal|2009Cited by 157
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancerMaria Vittoria Dieci, Valentina Guarneri, PierFranco Conte et al.|Annals of Oncology|2019Cited by 96
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluationAleix Prat, PierFranco Conte, Valentina Guarneri et al.|The Lancet Oncology|2020Cited by 75